True Diagnostics, Inc. Receives FDA 510(k) Clearance to Market VeriClear(TM) Digital Test Device for Early Result Pregnancy
SAN DIEGO, May 28, 2019 -- (Healthcare Sales & Marketing Network) -- True Diagnostics, Inc. (True), a leading company for Point of Care Answers, announced today that its VeriClear Digital Early Result Pregnancy Test has received 510(k) marketing clearanc... Diagnostics, FDA True Diagnostics, VeriClear, Pregnancy Test, chorionic gonadotropin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news